Loading…
Unihealth Hospitals (UNIHEALTH)₹544.35−2.03%Hospital
In the Mar 2026 quarter (consolidated), Unihealth Hospitals reported sales of ₹65.11 Cr, up 16.1% from Mar 2025, and net profit of ₹16.99 Cr, down 5.5% year on year. For the year to Mar 2026, sales were ₹132 Cr and net profit ₹45.97 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 22.04 | 27.05 | 43.09 | 56.07 | 67.08 | 65.11 |
| Expenses | 15.03 | 16.04 | 28.05 | 34.08 | 35.08 | 43.11 |
| Operating Profit | 7.01 | 10.01 | 15.01 | 21.01 | 32.03 | 22.03 |
| OPM % | 32.0% | 39.0% | 35.0% | 38.0% | 48.0% | 34.0% |
| Other Income | 1.01 | 1.01 | 2.01 | 1.01 | 3.01 | 2.01 |
| Interest | 1.99 | 1.99 | 1.99 | 0.99 | 0.99 | 0.99 |
| Depreciation | 0.99 | 0.99 | 1.99 | 3.99 | 3.99 | 5.99 |
| Profit before tax | 4.99 | 7.99 | 12.99 | 17.99 | 29.97 | 16.97 |
| Tax % | 17.0% | 28.0% | 29.0% | −2.0% | 4.0% | −2.0% |
| Net Profit | 3.99 | 5.99 | 8.99 | 17.98 | 28.97 | 16.99 |
| EPS (Rs) | — | — | — | — | 9.74 | 6.82 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 22.03 | 26.06 | 37.06 | 44.10 | 49.09 | 99.13 | 132 |
| Expenses | 20.03 | 20.06 | 25.06 | 30.07 | 31.09 | 62.15 | 78.19 |
| Operating Profit | 2.01 | 7.01 | 12.02 | 14.02 | 18.02 | 37.02 | 54.08 |
| OPM % | 10.0% | 25.0% | 31.0% | 31.0% | 36.0% | 37.0% | 41.0% |
| Other Income | 1.01 | 2.01 | 1.01 | 2.01 | 2.01 | 3.01 | 5.01 |
| Interest | 1.99 | 0.99 | 4.99 | 3.99 | 2.99 | 2.99 | 1.99 |
| Depreciation | 1.99 | 1.99 | 1.99 | 2.99 | 1.99 | 5.99 | 9.98 |
| Profit before tax | −0.99 | 4.99 | 4.99 | 8.99 | 13.98 | 29.98 | 45.93 |
| Tax % | 2.0% | 9.0% | 27.1% | 17.0% | 24.0% | 11.0% | 2.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.99 | 4.99 | 3.99 | 7.99 | 9.99 | 26.97 | 45.97 |
| EPS (Rs) | — | — | — | — | — | — | 16.44 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1.00 | 1.00 | 1.00 | 1.00 | 14.98 | 14.98 | 15.99 |
| Reserves | 4.00 | 8.99 | 12.99 | 25.99 | 69.95 | 86.00 | 122 |
| Borrowings | 40.96 | 38.94 | 37.95 | 38.97 | 14.99 | 21.99 | 33.00 |
| Other Liabilities | 11.94 | 8.96 | 11.95 | 11.94 | 9.95 | 61.70 | 83.59 |
| Total Liabilities | 57.90 | 57.89 | 64.89 | 77.90 | 110 | 185 | 254 |
| Fixed Assets | 34.93 | 34.92 | 35.91 | 36.89 | 35.89 | 67.79 | 83.80 |
| CWIP | 1.99 | 0.00 | 0.00 | 0.00 | 0.00 | 5.01 | 9.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 19.98 | 21.97 | 27.98 | 41.01 | 73.98 | 112 | 160 |
| Inventories | 0.99 | 0.99 | 1.99 | 1.99 | 1.99 | 3.99 | 6.98 |
| Trade receivables | 13.03 | 14.02 | 18.03 | 27.04 | 34.05 | 82.10 | 123 |
| Cash & equivalents | 0.99 | 1.99 | 1.99 | 1.99 | 28.93 | 15.95 | 9.98 |
| Total Assets | 57.90 | 57.89 | 64.89 | 77.90 | 110 | 185 | 254 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1.01 | 4.01 | 9.01 | 1.01 | 5.01 | 3.01 | 6.01 |
| Cash from investing activity | −1.01 | 0.00 | −4.02 | −5.02 | 0.00 | −5.02 | −19.05 |
| Cash from financing activity | 0.99 | −2.99 | −4.99 | 2.99 | 21.96 | −2.99 | 15.96 |
| Net cash flow | 0.00 | 1.01 | 0.00 | 0.00 | 27.03 | −5.01 | 2.01 |
| Capex | 2.54 | 0.37 | 1.31 | 2.33 | 2.39 | 16.24 | 31.26 |
| Free cash flow | −1.01 | 4.01 | 8.01 | −1.01 | 1.99 | −12.99 | −26.01 |
| CFO / OP % | 32.1% | 62.0% | 82.1% | 22.1% | 40.0% | 18.1% | 16.1% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 206 | 198 | 180 | 228 | 251 | 303 | 341 |
| Inventory days | 50 | 86 | 78 | 98 | 88 | 74 | 100 |
| Days payable | 382 | 91 | 79 | 137 | 104 | 104 | 138 |
| Cash conversion cycle | −124 | 193 | 181 | 189 | 236 | 274 | 305 |
| Working capital days | 24 | 137 | 87 | 141 | 203 | 239 | 321 |
| ROCE % | — | 13.9% | 19.9% | 21.9% | 20.0% | 25.0% | 23.9% |
For the Mar 2026 quarter, Unihealth Hospitals reported sales of ₹65.11 Cr, up 16.1% year on year and net profit of ₹16.99 Cr, down 5.5% year on year. The operating margin was 34.0%.
Unihealth Hospitals' sales for the year to Mar 2026 were ₹132 Cr.
Net profit for the year to Mar 2026 was ₹45.97 Cr. Earnings per share over the same trailing period were ₹16.44.
Unihealth Hospitals reported borrowings of ₹33 Cr at Mar 2026, against cash and equivalents of ₹9.98 Cr.
Cash from operations was ₹6.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹26.01 Cr.